Cancer Prostate Cancer

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Prostate Cancer Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Prostate Cancer Projects
--AstraZeneca Plc
--Ardana plc
--Bristol-Myers Squibb Company
--Barr Pharmaceuticals Inc
--CYTOGEN Corporation
--Celgene Corporation
--Dendreon Corp
--Debiopharm Group
--Ipsen Ltd
--Genzyme Corporation
--Johnson & Johnson
--Isis Pharmaceuticals Inc
--Oakwood Laboratories, L.L.C.
--Medarex Inc
--Pfizer Inc
--OncoGenex Technologies Inc.
--Pierre Fabre Medicament
--PharmaMar
--Therion Biologics Corporation
--Sanofi-Aventis

--Top Companies in early stage Prostate Cancer Projects
--AmpliMed Corporation
--AEterna Zentaris Inc
--Ariad Pharmaceuticals Inc
--Aphios Corporation
--Bristol-Myers Squibb Company
--ARIUS Research Inc
--Colby Pharmaceutical Company
--Cell Genesys Inc
--GTX INC/TN
--CYTOGEN Corporation
--Marillion Pharmaceuticals, Inc
--Introgen Therapeutics Inc
--Oakwood Laboratories, L.L.C.
--Merck & Co Inc
--Progenics Pharmaceuticals Inc
--Peregrine Pharmaceuticals Inc
--Takeda Pharmaceutical Company Limited
--Raven biotechnologies, inc.
--ViroTarg Pty Ltd
--Twinstrand Therapeutics

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View